Skip to content

Build your pharmacy right the first time.

503A consulting for licensing, cleanroom buildout, USP readiness, SOPs, and operational growth.

  • Roadmap in 5 business days
  • 503A-exclusive advisory
  • Multi-state licensing support
5business days

Written consultation roadmap with owners, timelines, and risk areas.

503Aexclusive focus

Sterile and non-sterile compounding pharmacy advisory only.

Nation-wideoperations reach

Multi-state licensing strategy and sequencing support.

Beyond checklists. Built for inspection reality.

Pinnacle helps translate complex 503A requirements into operating systems your team can use and inspectors can evaluate.

USP 795/797/800 programs
Environmental monitoring
CAPA and QAPI
Supplier qualification
Molecular medicine technology interface in a modern lab

Who we serve.

Pinnacle works with pharmacy owners and operators when regulatory risk, buildout decisions, or growth plans require experienced judgment.

Startups

Opening a 503A pharmacy and needing a path from entity setup to first dispense.

In-development teams

Already have a location, license work, or buildout underway and need the gaps closed.

Operating pharmacies

Need USP readiness, updated SOPs, mock audit support, or growth without compliance drift.

Expansion leaders

Adding states, peptides, new formulation categories, personnel, or advisory capacity.

Engagement Types

The kind of results we deliver.

Illustrative engagement outcomes based on the scope of work Pinnacle provides across licensing, compliance, and buildout phases.

Zero deficiencies on first state board inspection

Illustrative · Newly opened sterile pharmacy

Mock audit, EM trending corrections, and full SOP gap closure completed six weeks before the board visit.

Delivered in 6 weeks

Three-state licensure in one quarter

Illustrative · Startup compounding operation

Sequenced DEA registration, state board applications, and NABP credentialing across three target states.

60+ SOP library delivered before first dispense

Illustrative · In-development 503A pharmacy

USP 795/797/800 SOPs, batch record system, and MFR templates delivered prior to opening day.

Strategic support across the pharmacy lifecycle.

Services are organized around the points where pharmacy projects usually stall: licensing, facilities, quality systems, and growth.

Start and license

For pharmacists, owners, and investors moving from concept to first dispense.

Initial consultation

Gap analysis, SOP audit, FDA history review, facility assessment, and a written roadmap in 5 business days.

Business and license roadmaps

Entity guidance, DEA strategy, state board applications, NABP credentialing, PCAB planning, and multi-state sequencing.

Build the operation

For teams creating the physical, procedural, and quality foundation inspectors expect.

Cleanroom design and buildout

ISO classification planning, HVAC review, hood selection, workflow design, contractor coordination, and certification support.

SOP development

Sterile, non-sterile, hazardous, QA, EM, MFR, batch record, training, and document-control libraries.

Pass inspection and grow

For active pharmacies strengthening compliance, expanding scope, and improving throughput.

Regulatory and compliance

USP 795/797/800 programs, EM trending, CAPA, QAPI, change control, mock audits, and inspection readiness.

Materials and suppliers

Approved supplier lists, vendor qualification, incoming inspection, material specs, quarantine systems, and API review.

What to expect.

Clear scope, written deliverables, and direct accountability from the first call.

01

Roadmap in five business days

Your first engagement turns a messy pharmacy build into a prioritized action plan with owners, timelines, and risk areas.

02

Leadership-led communication

Clients work through Pinnacle leadership, with one accountable point of contact and written updates throughout the project.

03

Operator-level guidance

The advice comes from inside real compounding operations, where cleanrooms, SOPs, inspections, and batches have to hold up.

04

Regulatory watchfulness

Peptide and 503A bulk-substance guidance is handled carefully as FDA review, enforcement, and list status continue to evolve.

Initial Consultation

Start with a written roadmap.

The initial consultation maps compliance risks, facility requirements, and licensing paths before any larger scope begins.

From $750one-off engagement
  • Gap analysis

    Situation review across licensing, facilities, quality systems, and SOP status.

  • Priority action plan

    Written roadmap with owners, timelines, and ranked risk areas, in 5 business days.

  • Next-step scope

    State board sequencing strategy and a clear path to the right engagement level.

Request Consultation
Pinnacle 503A Advisors

Confidential Gap Analysis Report

PINN
84%
Facility Readiness Index
Requires Action: 2 Gaps Identified
Scope: USP 795 / 797 / 800
Roadmap: Delivered in 5 Days
Airflow Cleanroom Ventilation Integrity (USP 797)
Hazardous Chemical Handling Workflow (USP 800)
!SOP Document Control: EM trending protocols missing
PIC Multi-State Coverage: licensing pending coverage
Priority Deliverable Mockup Certified Seal

Ready to build it right the first time?

Start with a focused consultation, compliance review, and written roadmap before you commit to a larger engagement.

Request Consultation